Coagulation analyzers are used to measure coagulation studies such as Thrombin Time (TT), Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and D-Dimer test in a fast and simple way. Coagulation analyzers also provide clinical prevention of heart attacks, by measuring various biomarkers present in the blood. Moreover, coagulation analyzers help in quantifying blood platelet levels for patients suffering from various diseases. They offer optimized test results at relatively low costs. Therefore, there is an increasing demand for coagulation analyzers in specialty centers and other healthcare facilities.
Get PDF Brochure with COVID19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1255
Increasing prevalence of cardiovascular diseases across the globe is expected to propel the growth of the global coagulation analyzers market during the forecast period. For instance, according to the Centre for Disease Control and Prevention (CDC), in 2017, atrial fibrillation affected around 2.7 to 6.1 million Americans, and the prevalence is expected to increase with increase in aging population.
Moreover, rising adoption of coagulation analyzers in ambulatory surgical centers is expected to drive the global coagulation analyzers market growth. These devices are extensively used to measure coagulation status. For instance, in 2016, Hoffmann-La Roche announced the launch of CoaguChek INRange system that helps both doctors and patients to check their coagulation status and monitor Vitamin K Antagonist (VKA) therapy.
Key players operating in the global coagulation analyzers market include Alere Inc., Beckman Coulter, Inc. (Danaher), Nihon Kohden Corporation, International Technidyne Corporation, Diamond Diagnostics, Sysmex Corporation, Instrumentation Laboratory, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and Siemens AG.
Market players are focused on launching novel products to strengthen their product portfolio, as well as their market presence. For instance, in 2016, Instrumentation Laboratory announced the commercialization of HemosIL ReadiPlasTin, a new PT reagent, in markets throughout the world, expanding the Company’s growing portfolio of liquid, ready-to-use assays.
Purchase This Premium Report Here With Discounted Price (Flat US $2000 Off) – https://www.coherentmarketinsights.com/promo/buynow/1255
Reasons to Purchase this Report
• Current and future of global Coagulation Analyzers market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027